Shock (Septic, Cardiogenic, Hypovolemic, Obstructive, Anaphylactic) — Clinical Documentation Guide (2026)

This Clinical Documentation Guide (CDG) provides AAPC/AHIMA-credentialed coders and CDI specialists with comprehensive coding, clinical, and documentation guidance for shock in all its major subtypes — septic, cardiogenic, hypovolemic, obstructive, and anaphylactic. Content reflects FY2026 ICD-10-CM Official Guidelines (effective October 1, 2025), incorporating sequencing mandates for septic shock under Guideline I.C.1.d.5, HCC v28 RAF weights, MS-DRG impact analysis, CPT 2026 procedure codes, and AHIMA/ACDIS-compliant CDI query templates. Shock codes carry MCC status across virtually all subtypes — accurate documentation and sequencing directly drive reimbursement, risk adjustment, and audit defense.

🔍 1. Definition

Shock is a life-threatening, time-sensitive syndrome of acute circulatory failure resulting in inadequate oxygen delivery to meet cellular metabolic demands, leading to cellular dysfunction, organ injury, and death if untreated. The clinical hallmark is end-organ hypoperfusion — not merely hypotension. Per the NCBI Shock Reference, the cardinal features are: (1) hemodynamic instability, (2) evidence of tissue hypoperfusion, and (3) cellular metabolic dysfunction.

Critical documentation principle: Isolated hypotension (e.g., SBP < 90 mmHg) without documented end-organ hypoperfusion — such as elevated lactate, acute kidney injury, altered mental status, oliguria, or abnormal liver function — does not automatically meet clinical criteria for shock. Documentation must reflect both the hemodynamic instability and the evidence of impaired perfusion to support the diagnosis.

The five principal shock subtypes recognized in ICD-10-CM FY2026 are:

• Septic shock (R65.21): Shock due to systemic infection with persistent hypotension requiring vasopressors and lactate >2 mmol/L despite adequate fluid resuscitation — per Sepsis-3 definition (Singer et al., JAMA 2016).
• Cardiogenic shock (R57.0): Pump failure with SBP <90 mmHg for >30 minutes, cardiac index (CI) <2.2 L/min/m², pulmonary capillary wedge pressure (PCWP) >15 mmHg, and evidence of hypoperfusion.
• Hypovolemic shock (R57.1): Reduced intravascular volume from hemorrhage, dehydration, or third-spacing, causing inadequate preload and reduced cardiac output.
• Obstructive shock: Mechanical obstruction to blood flow — classically pulmonary embolism (I26.x), cardiac tamponade (I31.4), or tension pneumothorax. Coded via the underlying cause in ICD-10-CM.
• Anaphylactic shock (T78.2xxA, T80.5xxA, T88.6xxA, T78.0x-T78.09): Severe, systemic allergic response causing distributive shock via massive histamine release and vasodilation.

🗂️ 2. Alternative Terminology

Clinical staff use varied terminology in documentation. The following table lists formal, colloquial, and lay terms that coders and CDI specialists must recognize to support appropriate code assignment and query triggers.

🩺 3. Signs & Symptoms

Clinical documentation must reflect specific signs, symptoms, and objective markers supporting each shock subtype. CDI specialists should flag encounters where shock is clinically evident but not explicitly named or typed by the provider.

Universal Shock Indicators (all subtypes)

• Hypotension: SBP <90 mmHg or MAP <65 mmHg — necessary but not sufficient alone
• Tachycardia: HR >100 bpm (compensatory); may be absent in neurogenic shock (bradycardia)
• Altered mental status: Confusion, agitation, obtundation, coma — cerebral hypoperfusion
• Oliguria / anuria: UO <0.5 mL/kg/hr — renal hypoperfusion; supports AKI coding (N17.x)
• Elevated lactate: >2 mmol/L (tissue hypoperfusion marker); >4 mmol/L = refractory/severe
• Cool, clammy, mottled skin: Peripheral vasoconstriction (hypovolemic, cardiogenic); warm/flushed in early distributive shock
• Capillary refill >2 seconds
• Metabolic acidosis: Lactic acidosis, elevated anion gap

Subtype-Specific Clinical Markers

🧭 4. Differential Diagnosis

Accurate shock subtype identification is critical for sequencing, DRG assignment, and HCC capture. The following differentials must be considered and — when co-existing conditions are confirmed — may require additional codes.

📋 5. Clinical Indicators for Coders/CDI

The following clinical indicators, when present in the medical record, should prompt documentation review and/or CDI query to ensure complete and accurate shock code assignment.

🦴 6. Anatomy & Pathophysiology

Understanding shock pathophysiology enables CDI specialists to recognize when hemodynamic deterioration reflects a specific shock subtype requiring documentation and when comorbid organ dysfunction codes must be captured.

Shared Pathophysiological Pathway

Regardless of subtype, all shock states converge on the same final common pathway: decreased oxygen delivery (DO2) relative to oxygen consumption (VO2) → anaerobic metabolism → lactate accumulation → cellular energy failure → organ dysfunction → death. Per UpToDate: Shock Definition and Classification, DO2 = CO × CaO2, where cardiac output (CO) = HR × SV, making any reduction in HR, SV, or arterial oxygen content a potential trigger.

Subtype-Specific Pathophysiology

• Septic shock: Pathogen-associated molecular patterns (PAMPs) activate innate immunity → cytokine storm (TNF-α, IL-1, IL-6) → endothelial dysfunction → vasoplegia (profound ↓SVR) → distributive hypoperfusion. Myocardial depression (sepsis cardiomyopathy) further reduces CO. Microvascular thrombosis and capillary leak compound organ injury. Per Sepsis-3 criteria (JAMA 2016).
• Cardiogenic shock: Acute loss of left ventricular contractility (most commonly from AMI — per AHA/ACC 2022 Cardiogenic Shock Guidelines) → ↓SV → compensatory ↑SVR → further ↑afterload → vicious cycle of worsening pump failure. Pulmonary edema results from ↑LVEDP and ↑PCWP.
• Hypovolemic shock: ↓Preload from blood/fluid loss → ↓SV → ↑HR, ↑SVR (compensatory) → insufficient to maintain CO → end-organ ischemia. Four hemorrhagic shock classes (I–IV) based on estimated blood loss per ATLS 10th Edition: Class III (>30% EBL) and IV (>40% EBL) carry life-threatening hemodynamic compromise.
• Obstructive shock: Mechanical impedance to RV outflow (PE) or ventricular filling (tamponade, tension pneumo) → ↓CO despite normal/↑cardiac filling pressures. Tamponade: pericardial fluid compresses cardiac chambers (pulsus paradoxus reflects inspiratory ↓LV filling). PE: acute RV dilation → interventricular septal shift → ↓LV preload.
• Anaphylactic shock: IgE-mediated mast cell/basophil degranulation → histamine, tryptase, leukotrienes, prostaglandins → ↓↓SVR + ↑vascular permeability + bronchospasm. The distributive pattern is similar to septic shock but onset is rapid (seconds to minutes). Per AAAAI/ACAAI Anaphylaxis Guidelines 2020.

Organ Dysfunction Coding Opportunities

Shock-induced organ dysfunction must be documented and coded separately when present. Each complication is typically an MCC or CC that significantly affects DRG assignment:

• Acute kidney injury (N17.0–N17.9) — most common; document stage (oliguric, anuric, requiring dialysis)
• Acute respiratory failure (J96.00–J96.01) — type 1 (hypoxic) vs. type 2 (hypercapnic)
• Acute hepatic failure (K72.00–K72.01) — "shock liver," transaminitis >1000 IU/L
• DIC (D65) — septic, obstetric, and traumatic shock
• Encephalopathy (G93.40, G93.41) — septic encephalopathy when provider-documented
• Coagulopathy (D68.9 or specific) — distinguish from DIC

💊 7. Medication Impact / Treatment

Vasopressor and inotrope administration is the pharmacologic hallmark of hemodynamically significant shock. Documentation of which agents were used, for how long, and at what doses supports clinical validity for shock diagnosis and has direct impact on HCPCS coding (Part B/outpatient) and nursing acuity capture.

Vasopressors (First-Line)

• Norepinephrine (Levophed): First-line vasopressor for septic shock per Surviving Sepsis Campaign 2021. Acts on α1-adrenergic receptors → ↑SVR. HCPCS: typically J3490 (unlisted drug) or report by NDC.
• Vasopressin: Second-line agent to reduce norepinephrine requirements in septic shock; acts on V1 receptors. HCPCS: J3364 (not separately billable inpatient; J3490 outpatient).
• Epinephrine (J0171): Preferred for anaphylactic shock (IM auto-injector or IV infusion); also used in refractory septic/cardiogenic shock. HCPCS J0171 per 0.1 mg.
• Dopamine (J1265): No longer first-line for septic shock (higher arrhythmia risk per De Backer NEJM 2010); still used in certain cardiogenic shock scenarios. HCPCS J1265 per 40 mg.
• Dobutamine (J1250): Inotrope for cardiogenic shock; ↑CO without significant vasoconstriction. HCPCS J1250 per 250 mg.

Adjunctive Medications

• Hydrocortisone (J1720): For septic shock refractory to vasopressors — 200 mg/day IV per Surviving Sepsis Campaign 2021. HCPCS J1720 (up to 100 mg) or J1710 (up to 25 mg); inpatient covered under DRG — not separately billable Part B inpatient.
• Diphenhydramine + H2 blocker: Adjunctive for anaphylactic shock (not first-line; epinephrine remains first-line).
• Broad-spectrum antibiotics: Mandatory within 1 hour for septic shock per Surviving Sepsis Campaign; selection drives organism-specific coding (A41.x).
• IV crystalloids (0.9% NS or LR): 30 mL/kg initial bolus for septic shock; large-volume resuscitation for hypovolemic shock. Balanced crystalloids preferred per SMART Trial NEJM 2018.
• Naloxone (J2310): For opioid-related distributive shock/hemodynamic compromise. HCPCS J2310 per 1 mg.
• Morphine (J2270): Used in cardiogenic shock/acute pulmonary edema context (use with caution; CAUTION-HF data suggests potential harm). HCPCS J2270 per 10 mg.

Mechanical Circulatory Support

• Intra-aortic balloon pump (IABP): CPT 33967/33968 insertion/removal; augments coronary perfusion in cardiogenic shock
• Percutaneous VAD (Impella, TandemHeart): CPT 33990 (insertion, femoral) / 33991 (insertion, femoral, open) / 33992 (removal) / 33993 (repositioning)
• ECMO: CPT 33960–33966; used for refractory cardiogenic or septic shock with combined cardiac and respiratory failure

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides